|
Mutation Information
|
Mutation Site
|
T1753V |
|
Mutation Type
|
Nucleotide level |
|
Gene/Protein/Region Type
|
BCP |
|
Country
|
China |
Literature Information
|
PubMed PMID
|
18844615
|
|
Disease
|
Hepatocellular carcinoma
|
|
Published Year
|
2008 |
|
Journal
|
The American journal of gastroenterology |
|
Title
|
HBV A1762T, G1764A mutations are a valuable biomarker for identifying a subset of male HBsAg carriers at extremely high risk of hepatocellular carcinoma: a prospective study. |
|
Author
|
Fang ZL,Sabin CA,Dong BQ,Ge LY,Wei SC,Chen QY,Fang KX,Yang JY,Wang XY,Harrison TJ |
|
Evidence
|
The total prevalence of the C1653T mutation from cases and controls is 20% (12/60) and that of T1753V is 28.4% (29/102) (Table 6).
|
|
|
HBV Mutation Detail Information